PDR Drug Updates

Get more information on PDR's monthly Drug Updates, including the latest in FDA news and drug labeling updates.

Type Drug Name Here

2024 eDrug Updates

January 2024: Innovative Therapy Brings Relief to Patients with Rare Soft-Tissue Tumors
February 2024: Attacking ASCVD via an Anti-inflammatory Approach
March 2024: An Accelerated Vaccine Approval Helps Address Viral Health Threat
April 2024: Vasodilator Receives First Approval for Severe Frostbite
May 2024: Oral Antihypertensive Approved for Resistant High Blood Pressure
June 2024: Novel Antibiotic Approved to Treat Trio of Complex Bacterial Infections
July 2024: First Approval in Decades for Female Adults with UTI
August 2024: Chronic Esophageal Disease Gets New Treatment Approval
September 2024: Improving Quality of Life for Those with Hyperhidrosis
October 2024: Advancing the Fight Against Influenza
November 2024: Needle-free Treatment for Anaphylaxis
December 2024: Transformative Treatment for Degenerative Disease

Drug Information
Resources
Careers

Drug Communication
FAQs
Report Adverse Events

Contact Us

U.S.-based MDs, DOs, NPs and PAs in full-time patient practice can register for free access to the Prescribers’ Digital Reference on PDR.net. PDR.net is to be used only as a reference aid, it is not intended to be a substitute for the exercise of professional judgement. You should confirm the information on the PDR.net site through independent sources and seek other professional guidance in all treatment and diagnosis decisions.

1-888-227-6469